VIDASAFE D 100/5 TABLETS

Product Description

VIDASAFE D 100/5 TABLETS
Advanced Dual-Action Oral Antidiabetic Formula

VIDASAFE D 100/5 Tablets are a powerful bilayered formulation designed for optimal glycemic control in adults with Type 2 Diabetes Mellitus. Each film-coated tablet delivers the synergistic combination of:

Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 5 mg
Vildagliptin IP (Sustained Release) 100 mg

Key Benefits:

Dual Mechanism of Action: Combines an SGLT2 inhibitor (Dapagliflozin) and a DPP-4 inhibitor (Vildagliptin SR) to improve insulin sensitivity, promote glucose excretion, and regulate blood sugar levels throughout the day.

Once-Daily Convenience: The sustained-release formulation ensures prolonged therapeutic action with just one tablet daily.

Enhanced Patient Compliance: Bilayered technology supports targeted release and reduced pill burden.

Trusted Quality: Manufactured under stringent pharmaceutical standards ensuring purity, safety, and efficacy.

Industry Use:
Ideal for hospitals, pharmacies, clinics, medical wholesalers, and pharmaceutical distributors seeking effective Type 2 diabetes management solutions.